Fourteen Biomarkers and Subsequent Disability in Patients with Stroke Recurrence: Results from the SPARCL Trial
Higher levels of osteopontin, neopterin and NT-ProBNP and lower levels of HDL-c after stroke were independently associated with greater disability in case of recurrent stroke.
Authors
- Henrik Sillesen (ORCID: https://orcid.org/0000-0002-3302-6288)
- Pierre Amarenco (ORCID: https://orcid.org/0000-0002-3842-1236)
- Elena Meseguer (ORCID: https://orcid.org/0000-0002-7184-2614)
- Warren Bao
- Larry B. Goldstein (ORCID: https://orcid.org/0000-0001-7747-128X)
- Peter Ganz (ORCID: https://orcid.org/0000-0002-0437-8882)
- K.M.A. Welch
- Gregory M. Preston
Institutions
- University of Copenhagen (DK)
- San Francisco General Hospital (US)
- University of Kentucky (US)
- Inserm (FR)
- Pfizer (United States) (US)
- Rosalind Franklin University of Medicine and Science (US)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Laboratoire de Recherche Vasculaire Translationnelle (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- European Neurology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1159/000545149
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35